Stay updated on Oncolytics Biotech Press Releases
Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.

Latest updates to the Oncolytics Biotech Press Releases page
- Check6 days agoChange DetectedStock data on the Investor Overview has been updated to include new price and percentage figures, replacing the previous values. A new press release about pelareorep manufacturing patent protection through 2044 has been added, and an older ASCO-related press release has been removed.SummaryDifference3%

- Check14 days agoChange DetectedStock price changed from $0.83 (-$0.036, -4.15%) to $0.81 (-$0.012, -1.46%). This reflects updated pricing and daily performance data for the stock.SummaryDifference0.8%

- Check21 days agoChange DetectedStock information on the Investor Overview page was updated to reflect a current price of $0.87 with a change of -$0.013 and -1.48% on June 2, 2026. New items were added announcing Steve Glover's appointment to the Board and John McAdory's promotion to COO (June 1–2, 2026) and positive preclinical findings for pelareorep in combination with RAS-targeted approaches, while older items about durable responses in second-line RAS-Mutant MSS colorectal cancer and FDA alignment on a planned anal cancer study were removed.SummaryDifference3%

- Check28 days agoChange DetectedStock quote values were updated to $0.94, $0.035, and 3.89% with the date May 22, 2026. A new ASCO 2026 press release headline was added, while the prior April 6, 2026 data and FDA meeting headline were removed.SummaryDifference3%

- Check35 days agoChange DetectedThe NASD: ONCY stock quote on the investor overview page has been updated, showing a current price of $0.79 with a daily change of -$0.03 and -3.66%, replacing the prior values of $0.87, $0.002, and 0.23%.SummaryDifference0.9%

- Check42 days agoChange DetectedThe stock quote values were updated from $0.90 (-$0.02, -2.17%) to $0.87 (+$0.002, +0.23%), reflecting the latest intraday movement. This update shows the current price and the day's small positive delta relative to the previous close.SummaryDifference0.9%

Stay in the know with updates to Oncolytics Biotech Press Releases
Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.